CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Principal Accounting Officer sold 10,000 shares at $3.12 ($31,200)
- 4 Open-market sale EVP & Chief Medical Officer sold 153,000 shares at $3.50 ($535,500)
- 4 Open-market buy EVP & Chief Commercial Officer bought 100,000 shares at an average $3.26 ($325,550)
- 4 Open-market sale EVP & Chief Medical Officer sold 16,500 shares at $3.51 ($57,861)
- 4 Open-market buy EVP & Chief Commercial Officer bought 100,000 shares at $2.82 ($282,320)
- 4 Open-market buy CEO, President bought 114,000 shares at $2.63 ($300,002)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 34 · 664 filings